New Zealand markets open in 9 hours 53 minutes

Biostar Pharmaceuticals, Inc. (BSPM)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.00010.0000 (0.00%)
At close: 03:42PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 316.46k
Enterprise value 316.46k
Trailing P/E 0.18
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.99
Price/book (mrq)0.01
Enterprise value/revenue 1.00
Enterprise value/EBITDA 0.06

Trading information

Stock price history

Beta (5Y monthly) -3,298.49
52-week change 3-99.00%
S&P500 52-week change 324.19%
52-week high 30.0100
52-week low 30.0001
50-day moving average 30.0001
200-day moving average 30.0022

Share statistics

Avg vol (3-month) 311
Avg vol (10-day) 371
Shares outstanding 52.64M
Implied shares outstanding 63.16B
Float 82.21M
% held by insiders 10.00%
% held by institutions 10.00%
Shares short (31 Aug 2018) 4170.44k
Short ratio (31 Aug 2018) 43
Short % of float (31 Aug 2018) 47.74%
Short % of shares outstanding (31 Aug 2018) 46.46%
Shares short (prior month 31 Jul 2018) 4246.69k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:7
Last split date 305 Feb 2016

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2016
Most-recent quarter (mrq)30 Sept 2017

Profitability

Profit margin 294.01%
Operating margin (ttm)876.46%

Management effectiveness

Return on assets (ttm)4.25%
Return on equity (ttm)2.66%

Income statement

Revenue (ttm)317.79k
Revenue per share (ttm)0.12
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA 3.89M
Net income avi to common (ttm)934.35k
Diluted EPS (ttm)0.0000
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)364.97k
Total cash per share (mrq)0.14
Total debt (mrq)2.43M
Total debt/equity (mrq)6.71%
Current ratio (mrq)0.19
Book value per share (mrq)13.71

Cash flow statement

Operating cash flow (ttm)8.59M
Levered free cash flow (ttm)7.47M